AIIMS Delhi Restricts Unauthorized Social Media Use and Sharing of Patient Information
The AIIMS Delhi administration in New Delhi has issued a comprehensive set of social media guidelines this week, effective immediately, prohibiting students, staff, and affiliated bodies from using the institute's name, logo, or branding without prior approval. The new rules have been introduced in an effort to protect the premier medical institution's brand image and to safeguard patient confidentiality.
The official office memorandum applies widely across all levels of the country's premier medical institute. Those bound by the new regulations include undergraduate and postgraduate students, resident doctors, faculty members, researchers, and administrative staff. Furthermore, the guidelines cover student associations, various internal departments, and even third-party collaborators who are associated with the hospital.
Under the newly implemented rules, no individual or organization affiliated with AIIMS Delhi is permitted to use the institute's name, logo, emblem, or branding in any digital or print material. To use any of these official assets, individuals and groups must first obtain written permission from the concerned department.
The administration stated that this restriction extends to a wide range of promotional, digital, and physical content. This includes event posters, banners, social media posts, blogs, videos, and reels. It also bars the creation of social media handles that could create the impression of being official AIIMS accounts.
In addition to the branding restrictions, the guidelines strictly prohibit the disclosure of patient information, images, or case details on any social media platforms. The administration clarified that this ban applies to all such disclosures, even in cases where the patient is not directly identifiable from the shared information.
The official document cites legal obligations under medical ethics regulations and the Digital Personal Data Protection Act, 2023, as the key drivers behind these new restrictions. By enforcing these strict measures, the administration aims to ensure complete compliance with national data protection laws and medical ethics.
